New use may boost Lilly drug: Cymbalta could be next treatment for controversial illness fibromyalgia
It could be another Prozac moment. Eli Lilly and Co. is pitching its next star antidepressant drug, Cymbalta, for approval to treat the poorly understood pain of fibromyalgia. Regulators OK’d a drug specifically for fibromyalgia for the first time in June. The approval of Pfizer Inc.’s Lyrica sparked hope in fibromyalgia patients and advocates that more doctors will come to understand and diagnose the tricky condition, now that they have a medicine to treat it. That’s what happened 20 years…